CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Miami Beach, Florida, United States and 216 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Miami Beach, Florida, United States and 190 other locations
and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...
Phase 2, Phase 3
Miami, Florida, United States and 220 other locations
The researchers are doing this study to find out whether the study drug, SDX-7320, when combined with the standard chemotherapy eribulin, is an effec...
Phase 2
Miami, Florida, United States and 9 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Miami, Florida, United States and 226 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Fort Lauderdale, Florida, United States and 516 other locations
after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The prim...
Phase 2
Miami, Florida, United States and 121 other locations
CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small...
Phase 1
Miami, Florida, United States and 17 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Miami, Florida, United States and 505 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Miami Beach, Florida, United States and 275 other locations
Clinical trials
Research sites
Resources
Legal